二甲双胍对2型糖尿病患者血浆同型半胱氨酸水平的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Effects of Metformin on Homocysteine in Patients with Type 2 Diabetes Mellitus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的探讨二甲双胍对2型糖尿病患者血浆总同型半胱氨酸水平的影响。方法采用高效液相荧光检测的方法测定30例健康对照者3、0例2型糖尿病患者及服二甲双胍(0.75~1.00 g/天)治疗3个月后的糖尿病患者血浆总同型半胱氨酸的水平。结果2型糖尿病患者血浆总同型半胱氨酸水平(14.1±5.7μmol/L)高于对照组(9.5±3.4μmol/L,p<0.01),并且总同型半胱氨酸水平与年龄、体质指数、空腹血糖和空腹胰岛素明显正相关(p<0.05),与胰岛素敏感指数呈负相关。二甲双胍治疗3个月后,血浆总同型半胱氨酸水平(11.6±4.7μmol/L)比治疗前降低(p<0.05)。结论2型糖尿病患者血浆总同型半胱氨酸水平增高,二甲双胍治疗后可降低血浆总同型半胱氨酸水平。

    Abstract:

    Aim To investigate the effects of metformin on the levels of plasma total homocysteine(tHcy) in patients with type 2 diabetes mellitus(DM).Methods The levels of tHcy was determined by high performance liquid chromatography(HPLC) with fluorescence detection in 30 untreated type 2 DM cases and 30 healthy cases as control.30 DM patients were treated with metformin for three months(0.75~1.00 g/d),after the treatment,tHcy was detected again.Results tHcy was significantly higher in type 2 DM compared to controls(14.1±5.7 μmol/L vs 9.5±3.4 μmol/L,p<0.01),and was correlated with age,BMI,FBG,FINS(p<0.05),negative correlated with ISI(p<0.05).Following three months treatment with metformin,tHcy levels was significantly decreased(11.6±4.7 μmol/L,p<0.05).Conclusion The levels of tHcy increase in type 2 DM.After treating with metformin,the levels of tHcy decrease.

    参考文献
    相似文献
    引证文献
引用本文

韩其蔚,方彬,陈亚锋.二甲双胍对2型糖尿病患者血浆同型半胱氨酸水平的影响[J].中国动脉硬化杂志,2005,13(5):636~637.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2004-10-13
  • 最后修改日期:2005-08-27
  • 录用日期:
  • 在线发布日期: